Drug intelligence / Profile preview

glucosamine sulfate + chondroitin sulfate + methylsulfonylmethane

Development stage
Unknown
Lead developer
Universidad de Guadalajara
Modality
Small Molecules
Administration
Oral
01

Overview

This combination nutraceutical product consists of glucosamine sulfate, chondroitin sulfate, and methylsulfonylmethane (MSM). It is primarily used as a dietary supplement to support joint health and manage symptoms of osteoarthritis. Glucosamine and chondroitin are structural components of cartilage that promote the synthesis of the cartilage matrix while inhibiting degradative enzymes. MSM provides a source of organic sulfur and exerts anti-inflammatory and antioxidant effects. The University of Guadalajara has investigated this combination in clinical trials, including its potential role in managing secondary osteoporosis in specific populations, such as men with HIV, often as an adjunct to antiresorptive therapies like zoledronic acid. While some formulations under the brand name Colaren used in these trials may vary in composition (sometimes containing calcium and vitamin D), the glucosamine/chondroitin/MSM version is a recognized formulation studied by the institution.

Brand names
Colaren
Other names
Glucosamine/Chondroitin/MSM combinationGCM complex
02

Targets

NF-κBMMP12 (Macrophage Metalloelastase)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on glucosamine sulfate + chondroitin sulfate + methylsulfonylmethane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucosamine sulfate + chondroitin sulfate + methylsulfonylmethane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call